Corporate Profile
UG HEALTHCARE CORPORATION LIMITED 优格医疗集团 (“UG HEALTHCARE” OR THE “COMPANY” AND TOGETHER WITH ITS SUBSIDIARIES, THE “GROUP”) IS AN OWN BRAND MANUFACTURER THAT SPECIALISES IN THE MARKETING AND SALE OF PROPRIETARY UNIGLOVES® BRANDED HAND PROTECTION SOLUTIONS, AS WELL AS NON-GLOVE HYGIENE AND HEALTHCARE ANCILLARY PRODUCTS, THROUGH ITS ESTABLISHED GLOBAL DOWNSTREAM DISTRIBUTION NETWORK.
The Group owns and operates an extensive downstream network of distribution companies with a local presence in Europe, the United Kingdom, the USA, China, Africa, North America, and South America, where it primarily markets and sells its proprietary UNIGLOVES® portfolio of hand protection solutions and non-glove hygiene and healthcare ancillary products. These disposable and reusable hand protection products are used across a diverse range of industries that require safety and cross-infection protection and high hygiene standards, as well as catering to different applications and preferences. Along with its range of non-glove hygiene and healthcare ancillary products, the Group aims to address infection control, hygiene and care, dental care, and wound care across diverse industries.
The downstream distribution division is supported and complemented by the Group’s own upstream manufacturing division, manufacturing natural latex and nitrile disposable gloves under its UNIGLOVES® brand and third-party labels in its upstream manufacturing facilities located in Malaysia. The Group’s upstream manufacturing is certified by the British Standards Institution for ISO 9001:2015, ISO 13485:2016 and EN ISO 13485:2016 for the scope of manufacture and supply of natural latex and nitrile latex examination gloves. The Group’s proprietary brand of products conforms to various international standards and requirements.
The Group has a strategic investment in the joint development, management, and operation of active retirement homes in Malaysia.
UG Healthcare has been listed on the Singapore Exchange Securities Trading Limited under stock code 8K7 since 8 December 2014.
Our Business Strategy
The ethos of the Group has consistently been to nurture businesses for sustainable, long-term growth.
We are dedicated to delivering premier quality and reliable hand protection solutions, as well as non-glove hygiene and healthcare consumable products, to effectively support our diverse global customer base across four primary focuses: infection control, hygiene care, dental care, and wound care.
Our well-established and extensive global distribution network, spanning both developed and developing countries, offers valuable market intelligence. This enables us to gain insights into end users’ preferences and applications for our hand protection solutions, as well as non-glove hygiene and healthcare consumable products. These insights, in turn, drive our upstream disposable glove manufacturing capabilities and give us the flexibility to partner with cost-effective original equipment manufacturers (“OEMs”) to focus on innovation and production of “marketpreferred” products under our proprietary UNIGLOVES® international brand.
The integrated OBM supply chain business strategy, encompassing our upstream manufacturing, downstream global distribution network, and our UNIGLOVES® international brand, is an essential conduit for the Group’s flexibility, resilience, traceability, and sustainability. We are committed to continually enhancing our operational efficiency throughout our integrated OBM supply chain to ensure both seamlessness and effectiveness. This commitment not only strengthens our market position but also fosters long-term relationships with our partners and customers.
Leadership
The Board of Directors and the management team are committed to conduct our business activities in an economically, socially and environmentally responsible manner governed by high standards of internal controls and risk management practices to promote greater transparency and safeguard the interests of our stakeholders.
Mr. Wong Fook Choy Sunny serves as the Non-Executive Chairman and Independent Director of the Company, Chairman of the Remuneration Committee and a member of both the Audit and Nominating Committees. He joined the Board on 2 December 2024, and was last re-elected on 29 October 2025.
A practising advocate and solicitor of the Singapore Supreme Court, Mr. Sunny Wong was co-founder and managing director of the legal firm Wong Tan & Molly Lim LLC.
Mr. Sunny Wong graduated from the National University of Singapore with a Bachelor of Laws (Honours).
Mr. Sunny Wong is currently an Independent Director of KSH Holdings Limited listed on the Mainboard of SGX-ST.
Mr. Lee Jun Yih serves as the Joint Chief Executive Officer (“Joint CEO”), Executive Director and Finance Director of the Company. He joined the Board on 10 November 2014 and was last re-elected on 29 October 2025.
As Joint CEO, Mr. Lee works with his brother, Mr. Lee Jun Linn, the other Joint CEO, Executive Director and Chief Operating Officer (“COO”), to formulate the Group’s overall business and corporate policies and strategies. He oversees and manages the Group’s business and corporate development. As Finance Director, he oversees and controls the Group’s overall finance functions, which include financial planning, risk management, financial reporting and compliance, as well as capital allocation. Mr. Lee joined the Group in July 2011 and was appointed Joint CEO on 1 March 2025. He also serves as a director on the boards of the Company’s subsidiaries.
Mr. Lee graduated from Pembroke College, University of Cambridge with a Bachelor of Arts (Law) in June 2004. He began his career as a solicitor with Freshfields Bruckhaus Deringer, an international law firm, in its Hong Kong, London and Beijing offices in 2005 before joining JP Morgan, London, and UBS AG, Hong Kong as an analyst in the Investment Banking Division in August 2007 and April 2008, respectively. Thereafter, he joined AEGON Asset Management as an associate in January 2010.
He was admitted as a Solicitor of the High Court of the Hong Kong Special Administrative Region in September 2007.
Mr. Lee Jun Linn serves as the Joint CEO, Executive Director and COO of the Company. He joined the Board on 20 November 2014 and was last re-elected on 29 October 2024.
As Joint CEO, Mr. Lee works with his brother, Mr. Lee Jun Yih, the other Joint CEO, Executive Director and Finance Director, to formulate the Group’s overall business and corporate policies and strategies. He oversees and manages the Group’s business and corporate development. As COO, he is responsible for overseeing and managing the Group’s sales, marketing, and distribution platforms, including the development of marketing strategies and expansion of the Group’s global distribution network.
Mr. Lee joined the Group in April 2008 as Assistant General Manager of Unigloves Shanghai. On 1 March 2025, he was appointed the Joint CEO after ascending the ranks over the years. In addition, he is a director on the boards of the Company’s subsidiaries.
Mr. Lee graduated from University College London with a Bachelor of Science (Economics) degree in August 2006 and subsequently obtained a Master of Science (International Management (China)) degree from the School of Oriental & African Studies in London in December 2007.
Ms. Gillian Ng Lee Eng serves as the Independent and Non-Executive Director of the Company, Chairman of the Audit Committee, and a member of both the Nominating and Remuneration Committees. She joined the Board on 1 December 2023 and was last re-elected on 29 October 2024.
Ms. Gillian Ng has more than 15 years of experience in finance, accounting and human resource during her role as Finance Manager at EagleBurgmann KE Pte Ltd. As a key member of the management team, she had oversight over financial and management reporting, internal controls, tax and human resource functions.
She graduated with a Bachelor of Business in Accountancy from the Royal Melbourne Institute of Technology. She is also a member of the Singapore Institute of Directors and associate member of the Institute of Singapore Chartered Accountants.
Ms. Gillian Ng is currently an Independent Director of Medi Lifestyle Limited listed on the Catalist Board of SGX-ST.
Mr. Law Cheong Yan serves as the Independent and Non- Executive Director of the Company, Chairman of the Nominating Committee, and a member of both the Audit and Remuneration Committees. He joined the Board on 2 December 2024, and was last re-elected on 29 October 2025.
In May 2026, Mr. Law was appointed Senior Associate Director of Alpsedge Real Estate Pte. Ltd., a boutique consultancy specialising in capital markets transactions, investment-grade properties, development land, and collective sales. Since December 2025, he has also served as Director of Torrentium Capital Pte. Ltd., which focuses on mergers and acquisitions and provides fractional Chief Financial Officer and financial advisory services.
Previously, Mr. Law held the position of Head of Strategy of Sing-Ed Corporation Pte. Ltd. from February 2025 to April 2026, where he was instrumental in driving growth through business development and strategic partnerships. Prior to this role, he served as the Chief Operating Officer of Sing-Ed Corporation Pte. Ltd. until January 2025.
From August 2013 to January 2022, Mr. Law was Chief Financial Officer of Chip Eng Seng Corporation Ltd, overseeing financial strategy and operations. He rejoined Chip Eng Seng after more than nine years managing overseas subsidiaries of Singapore companies in the PRC and the US. From 1999 to 2004, he was Group Financial Controller of Chip Eng Seng and began his professional career as an auditor with KPMG Singapore from 1995 to 1999.
Mr. Law holds a Bachelor of Accountancy (Hons) degree from Nanyang Technological University, Singapore. He is also a member of ISCA and CPA Australia.